|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
Key: Meeting
Showing releases 376-400 out of 951. << < 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 > >>
Public Release: 23-Jul-2012
XIX International AIDS ConferenceFirst results of community health campaign in Uganda for HIV and other diseases A clinical study in a remote region of southwest Uganda has demonstrated the feasibility of using a health campaign to rapidly test a community for HIV and simultaneously offer prevention and diagnosis for a variety of other diseases in rural and resource-poor settings of sub-Saharan Africa. Contact: Jason Socrates Bardi
Public Release: 22-Jul-2012
XIX International AIDS ConferenceClinical study in rural Uganda shows high demand for antiretroviral drugs An ongoing clinical study in rural Uganda, begun in 2011, suggests that many people infected with HIV/AIDS would take antiretroviral drugs if they were available to them -- even before they developed symptoms from the disease. Contact: Jason Socrates Bardi
Public Release: 22-Jul-2012
 Annals of Internal MedicineEmbargoed news from Annals of Internal Medicine Below is information about articles being published in the July 22 issue of Annals of Internal Medicine. The information is not intended to substitute for the full articles as sources of information. Annals of Internal Medicine attribution is required for all coverage. Contact: Abbey Anderson
Public Release: 19-Jul-2012
Technology and InnovationThe search for medical technologies abroad A study published in the current issue of Technology and Innovation -- Proceedings of the National Academy of Inventors found that the search for medical technologies through "medical travel" can change the lives of patients and their family members. Contact: Judy Lowry
Public Release: 19-Jul-2012
XIX International AIDS Conference Journal of Acquired Immune Deficiency SyndromesNew report describes 7 essential steps toward an AIDS-free generation The end of AIDS is within our reach. But as the authors of a new special supplement in the August 2012 Journal of Acquired Immune Deficiencies (JAIDS) point out, new financial investments -- and renewed commitments -- from countries around the world will be critical to fully implement proven treatment and prevention tools already at hand and to continue essential scientific research. Contact: Todd Datz
Public Release: 19-Jul-2012
Keystone Symposia announces new 3-year grant to tackle major global health challenges Keystone Symposia has received a three-year $2.25 million grant from the Bill & Melinda Gates Foundation to tackle major global health challenges and extend the research enterprise to the developing world 
Bill & Melinda Gates Foundation
Contact: Yvonne Psaila
Public Release: 19-Jul-2012
Cell Host & MicrobeScripps Research scientists show potent new compound virtually eliminates HIV in cell culture A new study by scientists on the Florida campus of The Scripps Research Institute shows, in cell culture, a natural compound can virtually eliminate human immunodeficiency virus (HIV) in infected cells.
NIH/National Institute of Allergy and Infectious Diseases, Landenberger Foundation
Contact: Eric Sauter
Public Release: 19-Jul-2012
PLOS ONEStudy implements community-based approach to treat HIV-infection in rural Uganda New research from the University of Alberta's School of Public Health has demonstrated that community-based resources in rural Uganda can successfully provide HIV treatments to patients, where economic and geographical barriers would typically prevent access to care.
Canadian Institutes of Health Research
Contact: Kate Toogood
Public Release: 19-Jul-2012
Journal of Infectious DiseasesBelgian scientists develop way to detect superparasites Belgian scientists of the Institute of Tropical Medicine in Antwerp, Belgium, made a breakthrough in bridging high tech molecular biology research on microbial pathogens and the needs of the poorest of the poor. After sequencing the complete genome of Leishmania donovani (a parasite causing one of the most important tropical diseases after malaria) in hundreds of clinical isolates, they identified a series of mutations specific of "superparasites" and developed a simple assay that should allow tracking them anywhere.
European Commission
Contact: Jean-Claude Dujardin
Public Release: 18-Jul-2012
PLOS ONEFrequent antenatal screening dramatically reduces maternal mortality on Thai-Myanmar border Frequent antenatal screening has allowed doctors to detect and treat malaria in its early stages on the border of Thailand and Myanmar, dramatically reducing the number of deaths amongst pregnant women.
Wellcome Trust
Contact: Craig Brierley
Public Release: 17-Jul-2012
Global Health GovernanceReport focuses on sustainability of infectious disease surveillance Just as the globalization of trade and travel is rapidly evolving, so is the globalization of infectious diseases and the need for cooperative approaches to detect, prevent and control them. Contact: Debbie Morton
Public Release: 17-Jul-2012
PLOS ONEMarijuana use doubles risk of premature birth A large international study led by University of Adelaide researchers has found that women who use marijuana can more than double the risk of giving birth to a baby prematurely.
South Australian Government, New Enterprise Research Fund
Contact: Gus Dekker
Public Release: 16-Jul-2012
UW study plays pivotal role in today's FDA approval of HIV prevention drug The US Food and Drug Administration decided today, July 16, to approve the use of an HIV treatment drug for reducing the risk of acquiring HIV. In evaluating whether to allow TruvadaŽ to be prescribed for HIV prevention, the FDA reviewed the evidence from two studies -- the largest of which was conducted by the University of Washington's International Clinical Research Center. Contact: Bobbi Nodell
Public Release: 15-Jul-2012
NatureLa Jolla institute identifies critical cell in fighting E. coli infection Despite ongoing public health efforts, E. coli outbreaks continue to infiltrate the food supply, annually causing significant sickness and death throughout the world. But the research community is gaining ground. In a major finding, published today in the scientific journal Nature, researchers from the La Jolla Institute for Allergy & Immunology have discovered a molecule's previously unknown role in fighting off E. coli and other bacterial infections, a discovery that could lead to new ways to protect people from these dangerous microorganisms. Contact: Bonnie Ward
Public Release: 12-Jul-2012
Inexpensive paper-based diabetes test ideal for developing countries The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes a new, inexpensive paper-based device that is ideal for diabetes testing in rural and developing areas, such as in India and China. Contact: Michael Bernstein
Public Release: 12-Jul-2012
Liver TransplantationCurrent and former smokers at risk for recurrent hepatitis post-liver transplantation Transplant recipients who smoke or have smoked increase their risk of viral hepatitis reinfection following liver transplantation according to new research available in the July issue of Liver Transplantation, a journal published by Wiley on behalf of American Association for the Study of Liver Diseases. Findings suggest that tobacco in cigarettes may adversely affect immune system response in patients transplanted for viral hepatitis. Contact: Dawn Peters
Public Release: 12-Jul-2012
ScienceDiscovery opens door to attacking biofilms that cause chronic infections Using super-resolution microscopy and continuous fluorescent imaging, UC Berkeley's Veysel Berk has for the first time revealed the structure of bacterial biofilms, which are responsible for the tenacious nature of bacterial diseases such as cholera, chronic sinusitis and lung infections in CF patients. The picture of bacterial apartment buildings provides new targets for the development of drugs that can tear down these structures and expose them to antibiotics.
National Science Foundation, National Institutes of Health
Contact: Robert Sanders
Public Release: 12-Jul-2012
CellIn adult humans, brown fat is actually beige The calorie-burning and heat-generating brown fat found in full-grown humans is actually not quite brown; It's beige. So says a new study reported on July 12th in the journal Cell, a Cell Press publication, in which researchers fully characterize this promising obesity-fighting tissue in both mice and humans for the first time. Contact: Elisabeth Lyons
Public Release: 10-Jul-2012
New coral reef crustacean described and named after late reggae performer Bob Marley President Barack Obama has one. Comedian Stephen Colbert has one. Elvis Presley has one. Even computer software magnate Bill Gates has one. And now, Bob Marley -- the late popular Jamaican singer and guitarist -- also has one. So what is it that each of these luminaries have? The answer: they each have a biological species that has been named after them. Contact: Lily Whiteman
Public Release: 10-Jul-2012
LancetContraceptive use averts 272,000 maternal deaths worldwide Contraceptive use likely prevents more than 272,000 maternal deaths from childbirth each year, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health. Researchers further estimate that satisfying the global unmet need for contraception could reduce maternal deaths an additional 30 percent. Their findings were published July 10 by the Lancet as part of a series of articles on family planning.
Bill & Melinda Gates Foundation
Contact: Tim Parsons
Public Release: 10-Jul-2012
Lauren Sciences LLC's research team at Ben-Gurion University awarded Campbell Foundation grant to develop a V-Smart therapeutic for neuro-HIV Lauren Sciences LLC, a privately held biotechnology company furthering development of its new V-Smart nanovesicle platform technology, announced today the award of a grant from the Campbell Foundation to its research team at Ben-Gurion University. The grant from Campbell will support development of the novel V-Smart nanovesicles for systemic delivery of tenofovir across the blood brain barrier to the brain for treatment of neuro-HIV.
Campbell Foundation
Contact: Susan Rosenbaum
Public Release: 9-Jul-2012
Einstein receives nearly $5 million to study how Ebola causes infection The National Institutes of Health has awarded researchers at Albert Einstein College of Medicine of Yeshiva University a five-year, $4.8 million grant to study the molecular mechanism that allows the Ebola virus to cause infection and spread in animals.
National Institutes of Health
Contact: Kim Newman
Public Release: 9-Jul-2012
Proceedings of the National Academy of SciencesVaccine and antibiotics stabilized so refrigeration is not needed -- NIH study Researchers funded by the National Institutes of Health have developed a new silk-based stabilizer that, in the laboratory, kept some vaccines and antibiotics stable up to temperatures of 140 degrees Fahrenheit. This provides a new avenue toward eliminating the need to keep some vaccines and antibiotics refrigerated, which could save billions of dollars every year and increase accessibility to third world populations.
National Institutes of Health
Contact: Kate Egan
Public Release: 9-Jul-2012
 Dissertations and FeaturesMillions of diabetics could die of tuberculosis Recent research out of the University of Copenhagen demonstrates that the risk of tuberculosis breaking out is four times as likely if a person also suffers from diabetes. Meanwhile, as a diabetic, a person is five times as likely to die during tuberculosis treatment. The growing number of diabetics in Asia and Africa increases the likelihood that more people will succumb to and die from tuberculosis in the future. Contact: Doctor, Ph.D. Daniel Faurholt-Jepsen
Public Release: 9-Jul-2012
High-level commission finds an epidemic of bad laws is stifling the global AIDS response Landmark report finds evidence that enforcing punitive laws hinders HIV responses and wastes resources. Commission urgently calls for laws that protect human rights to save lives, save money and end the epidemic. Contact: Benjamin Humphrey
Showing releases 376-400 out of 951. << < 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 > >>
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||
|
|
 |
|
